Subedi Ganesh P, Satoh Tadashi, Hanashima Shinya, Ikeda Akemi, Nakada Hiroshi, Sato Reiko, Mizuno Mamoru, Yuasa Noriyuki, Fujita-Yamaguchi Yoko, Yamaguchi Yoshiki
Structural Glycobiology Team, Systems Glycobiology Research Group, Chemical Biology Department, RIKEN Advanced Science Institute, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
Protein Expr Purif. 2012 Mar;82(1):197-204. doi: 10.1016/j.pep.2011.12.010. Epub 2012 Jan 8.
Overproduction of recombinant proteins in Escherichia coli is often hampered by their failure to fold correctly, leading to their accumulation within inclusion bodies. To overcome the problem, a variety of techniques aimed at soluble expression have been developed including low temperature expression and/or fusion of soluble tags and chaperones. However, a general protocol for bacterial expression of disulfide bond-containing proteins has hitherto not been established. Single chain Fv fragments (scFvs) are disulfide bond-containing proteins often difficult to express in soluble forms in E. coli. We here examine in detail the E. coli expression of a scFv originating from an anti-carbohydrate MLS128 antibody as a model system. We combine three techniques: (1) tagging scFv with thioredoxin, DsbC and protein disulfide isomerase (PDI), (2) expressing the proteins at low temperature using the pCold vector system, and (3) using Origami E. coli strains with mutations in the thioredoxin reductase and glutathione reductase genes. We observed a high expression level of soluble MLS128-scFv in the Origami strain only when PDI is used as a tag. The recombinant protein retains full binding activity towards synthetic carbohydrate antigens. The developed "pCold-PDI" vector has potential for overproduction of other scFvs and disulfide-containing proteins in the Origami strains.
大肠杆菌中重组蛋白的过量生产常常因无法正确折叠而受阻,导致其在包涵体内积累。为克服这一问题,已开发出多种旨在实现可溶性表达的技术,包括低温表达和/或可溶性标签及伴侣蛋白的融合。然而,迄今为止尚未建立用于细菌表达含二硫键蛋白的通用方案。单链Fv片段(scFv)是含二硫键的蛋白,通常难以在大肠杆菌中以可溶性形式表达。我们在此详细研究了源自抗碳水化合物MLS128抗体的scFv在大肠杆菌中的表达,作为一个模型系统。我们结合了三种技术:(1)用硫氧还蛋白、DsbC和蛋白二硫键异构酶(PDI)标记scFv,(2)使用pCold载体系统在低温下表达蛋白,(3)使用硫氧还蛋白还原酶和谷胱甘肽还原酶基因发生突变的Origami大肠杆菌菌株。我们观察到,仅当使用PDI作为标签时,在Origami菌株中可溶性MLS128-scFv有高表达水平。该重组蛋白对合成碳水化合物抗原有完全的结合活性。所开发的“pCold-PDI”载体有潜力在Origami菌株中过量生产其他scFv和含二硫键的蛋白。